News and Trends 19 Dec 2022
Ordaōs and Yatiri Bio to tackle AML
Ordaōs has announced a joint development agreement to create new therapeutics for two novel targets in acute myeloid leukemia (AML) with Yatiri Bio. Ordaōs is a biotechnology company designing novel…